<DOC>
	<DOCNO>NCT00278304</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-ray kill tumor cell . Internal radiation use radioactive material place directly near tumor kill tumor cell . Giving radiation therapy different way may kill tumor cell . PURPOSE : This phase II trial study well give external-beam radiation together internal radiation work treat patient cervical cancer .</brief_summary>
	<brief_title>Radiation Therapy Treating Patients With Cervical Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine feasibility magnetic resonance-guided , endocavitary , high-dose rate brachytherapy implant patient stage IB-IVB cervical cancer . - Provide reliable dose-volume estimation base three-dimensional imaging-based treatment planning patient treat regimen . Secondary - Determine toxic effect treatment tolerance patient treat regimen . - Correlate three-dimensional dose-volume histogram organ risk treatment toxicity patient treated regimen . - Determine disease status , time pattern relapse , survival patient treat regimen . OUTLINE : Patients undergo external beam radiotherapy 4-5 day week 7 week . Patients also undergo MRI-guided high-dose brachytherapy comprise one brachytherapy implant week 3-6 implant . Brachytherapy may administer external beam radiotherapy . After completion study treatment , patient follow periodically 5 year . PROJECTED ACCRUAL : A total 20 patient accrue study .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm carcinoma cervix 1 follow cellular subtypes : Squamous cell Adenocarcinoma Adenosquamous cell Stages IBIVA disease Stage IVB disease allow provided impact quality life tremendous ( e.g. , `` frozen pelvis '' massive pelvic disease fistula formation , severe pain , bleed ) Measurable and/or evaluable disease MRI PATIENT CHARACTERISTICS : ECOG performance status 02 No physical physiological capacity would preclude study treatment No cognitively impair patient provide inform consent Not pregnant nursing Negative pregnancy test No contraindication MRI , include follow : Weight &gt; 136 kg Allergy MR contrast agent Pacemakers , cerebral aneurysm clip , shrapnel injury , implantable electronic device No significant unrelated systemic illness No serious infection No significant cardiac , pulmonary , hepatic , organ dysfunction would preclude study treatment Must medically fit receive anesthesia PRIOR CONCURRENT THERAPY : No prior definitive brachytherapy procedure Ring implant intravaginal cone relief excessive bleeding allow No prior definitive surgical oncologic procedure ( e.g. , radical hysterectomy ) Concurrent chemotherapy , immunotherapy , hormonal therapy allow</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2006</verification_date>
	<keyword>cervical adenocarcinoma</keyword>
	<keyword>cervical adenosquamous cell carcinoma</keyword>
	<keyword>cervical squamous cell carcinoma</keyword>
	<keyword>stage IB cervical cancer</keyword>
	<keyword>stage IIA cervical cancer</keyword>
	<keyword>stage IIB cervical cancer</keyword>
	<keyword>stage III cervical cancer</keyword>
	<keyword>stage IVA cervical cancer</keyword>
	<keyword>stage IVB cervical cancer</keyword>
</DOC>